Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | PLAU | P00749 | 1/20 | 0.50 |
| ▸ | NOS3 | P29474 | 1/20 | 0.50 |
| ▸ | NOS1 | P29475 | 1/20 | 0.50 |
| ▸ | NOS2 | P35228 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | CTH | P32929 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.37 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8883350 | 0.83 | RAB9A (0.50) | MAPTL3MBTL1RAB9AKDM4ENPC1 | |
| SCHEMBL29078757 | 0.81 | MAPT (0.47) | MAPTL3MBTL1RAB9AKDM4ENPC1 | |
| SCHEMBL162188 | 0.81 | L3MBTL1 (0.50) | MAPTL3MBTL1RAB9AKDM4ENPC1 | |
| Hydrochloric Acid SCHEMBL10515338 | 0.81 | RAB9A (0.48) | MAPTL3MBTL1RAB9AKDM4ENPC1 | |
| SCHEMBL2240052 | 0.81 | NOS3 (0.54) | MAPTL3MBTL1RAB9AKDM4ENPC1 | |
| Hydrochloric Acid SCHEMBL17893831 | 0.79 | NOS3 (0.52) | MAPTL3MBTL1RAB9AKDM4ENPC1 | |
| Hydrochloric Acid SCHEMBL6385939 | 0.79 | L3MBTL1 (0.49) | MAPTL3MBTL1RAB9AKDM4ENPC1 | |
| Hydrochloric Acid SCHEMBL28847816 | 0.79 | L3MBTL1 (0.49) | MAPTL3MBTL1RAB9AKDM4ENPC1 | |
| SCHEMBL22725591 | 0.79 | PLAU (0.47) | MAPTL3MBTL1RAB9AKDM4ENPC1 | |
| SCHEMBL5263024 | 0.78 | PLAU (0.50) | MAPTL3MBTL1RAB9AKDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210062353-A1 | LEVELING AGENT AND COPPER PLATING COMPOSITION COMPRISING THE SAME | SOULBRAIN CO., LTD. (KR) | 2021-03-04 | — | — | US | disclosed |
| US-20190161877-A1 | LEVELING AGENT AND COPPER PLATING COMPOSITION COMPRISING THE SAME | SOULBRAIN CO., LTD. (KR) | 2019-05-30 | — | — | US | disclosed |
| EP-2594555-B1 | HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR | ASKA PHARM CO LTD (JP) | 2018-03-07 | — | — | EP | disclosed |
| US-9200008-B2 | Heterocyclic compound and p27Kip1 degradation inhibitor | ASKA PHARMACEUTICAL CO., LTD. (JP) | 2015-12-01 | — | — | US | disclosed |
| EP-2594555-A1 | HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR | ASKA Pharmaceutical Co., Ltd. (JP) | 2013-05-22 | — | — | EP | disclosed |
| US-20130079306-A1 | HETEROCYCLIC COMPOUND AND p27Kip1 DEGRADATION INHIBITOR | ASKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-28 | — | — | US | disclosed |
| US-6884821-B1 | Carboxylic acid derivatives and drugs containing the same | EISAI CO., LTD. (JP) | 2005-04-26 | — | — | US | disclosed |
| EP-1216980-A1 | CARBOXYLIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME | Eisai Co., Ltd. (JP) | 2002-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079306-A1 | HETEROCYCLIC COMPOUND AND p27Kip1 DEGRADATION INHIBITOR | CDKN1A, SKP2, CCNI | MAPT 4033/4885L3MBTL1 2920/4885RAB9A 2990/4885 |
| US-20190161877-A1 | LEVELING AGENT AND COPPER PLATING COMPOSITION COMPRISING THE SAME | TET2, DPM1, SUCLG1 | MAPT 1663/4885L3MBTL1 1087/4885RAB9A 2405/4885 |
| US-20210062353-A1 | LEVELING AGENT AND COPPER PLATING COMPOSITION COMPRISING THE SAME | TPMT, TTC14, NACA | MAPT 1524/4885L3MBTL1 1128/4885RAB9A 3364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.